Request Information

News

Media coverage of Auris Health

Contact us
news-auris-robotics-in-medicine-1800x1200 news-auris-robotics-medicine-health-1800x1200

Auris Health Announces Late-Breaking Results from First-in-Human Study of Monarch™ Platform

Data Presented at CHEST 2019 Demonstrates Efficacy of Monarch to Successfully Reach Nodules and Biopsy Tissue * NEW ORLEANS – October 23, 2019 – Auris Health, Inc. (“Auris Health”), part of Johnson & Johnson Medical Devices Companies, today announced results from a study demonstrating the safety and feasibility of the Monarch Platform, a first-of-its-kind robotic technology indicated for use in diagnostic and therapeutic bronchoscopic procedures. Data from the BENEFIT study was presented in a late-breaking session at the CHEST 2019 Conference in New Orleans by Alexander C. Chen, M.D., of St. Louis, Mo.

Continue Reading

Auris Health Celebrates 1,000 Cases with the Monarch™ Platform

REDWOOD CITY – August 22, 2019 – Auris Health, Inc., part of Johnson & Johnson Medical Devices Companies, today announced that physicians have performed over 1,000 bronchoscopic procedures using the Monarch™ Platform. Auris gained FDA clearance for diagnostic and therapeutic bronchoscopic procedures on the Monarch Platform in the Spring of 2018.

Continue Reading

Independent Feasibility Study Demonstrates High Navigation Success with Auris Health’s Monarch™ Platform for Robotic-Assisted Bronchoscopy

Researchers conclude the Monarch™ Platform overcomes some limitations of conventional bronchoscopic systems in diagnosing lung nodules

Continue Reading

Auris Health Announces Early Results from First-In-Human Study of Monarch™ Platform

Ongoing BENEFIT Study of Monarch Platform Indicates Safety, Feasibility and Successful Localization of Lung Nodules in 92% of Cases

Continue Reading

Johnson & Johnson Announces Completion of Acquisition of Auris Health, Inc.

Auris will Enable Johnson & Johnson to Deliver on the Promise of Digital Surgery and Drive Better Outcomes for Patients

Continue Reading

Johnson & Johnson Announces Agreement to Acquire Auris Health, Inc.

Auris Health’s Robotic Platform Expands Johnson & Johnson’s Digital Surgery Portfolio

Continue Reading

Auris Health Announces $220 Million Growth Financing

Funds Will Be Used to Advance Commercialization and Development of Next-Generation Robotic Interventional Technology

Continue Reading

Auris Health Announces Results From New Study of Monarch™ Platform Presented in Late-Breaking Session at CHEST 2018

ACCESS Study Demonstrates Ability of Monarch to Successfully Reach Nodules and Biopsy Tissue

Continue Reading

Auris Health Announces Collaboration with Ethicon to Enable Bronchoscopic Ablation of Lesions in the Lung

Companies Collaborate to Integrate the NeuWave™ Flexible Microwave Ablation Technology with Auris’s Monarch™ Platform for Robotic Bronchoscopy

Continue Reading